DIMENSIONAL FUND ADVISORS LP
Position in VRTX — Vertex Pharmaceuticals Inc / Ma
CIK 354204
AUSTIN, TX
Position in VRTX
as of Mar 31, 2026
· filed May 7, 2026
Position Value
$441,780,774
+$13,056,358 QoQ
Shares Held
989,342
+4.6% QoQ
Ownership
0.390%
of shares outstanding
% of Portfolio
0.09%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 77.34777255994388.ToString("F0")%
Shared 11.656939662927481.ToString("F0")%
None 10.995287777128638.ToString("F0")%
Common Shares in VRTX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026DIMENSIONAL FUND ADVISORS LP holds $5,003,215,874 across 223 Biotechnology names. VRTX ranks #1 (8.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
This page
|
989,342 | $441,780,774 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
513,060 | $396,410,676 | |
| 3 | JAZZ |
Jazz Pharmaceuticals plc
|
1,895,215 | $358,290,394 | |
| 4 | BMRN |
Biomarin Pharmaceutical Inc
|
3,802,930 | $214,827,514 | |
| 5 | ROIV |
Roivant Sciences Ltd.
|
7,475,866 | $207,081,486 | |
| 6 | INCY |
Incyte Corp
|
1,975,544 | $185,938,199 | |
| 7 | EXEL |
Exelixis, Inc.
|
4,299,597 | $184,409,714 | |
| 8 | HALO |
Halozyme Therapeutics, Inc.
|
2,079,827 | $134,419,216 |
All Filings in VRTX
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $441,780,774 | 989,342 | Shares | Sole | 2026-05-07 | |
| 2025-12-31 | $428,724,416 | 945,660 | Shares | Sole | 2026-02-12 | |
| 2025-09-30 | $306,883,619 | 783,586 | Shares | Sole | 2025-11-12 | |
| 2025-06-30 | $265,440,259 | 596,227 | Shares | Sole | 2025-08-12 | |
| 2025-03-31 | $293,742,254 | 605,879 | Shares | Sole | 2025-05-13 | |
| 2024-12-31 | $252,701,094 | 627,517 | Shares | Sole | 2025-02-13 | |
| 2024-09-30 | $301,282,543 | 647,808 | Shares | Sole | 2024-11-07 | |
| 2024-06-30 | $310,741,202 | 662,957 | Shares | Sole | 2024-08-09 | |
| 2024-03-31 | $245,753,093 | 587,912 | Shares | Sole | 2024-05-10 | |
| 2023-12-31 | $238,118,536 | 585,216 | Shares | Sole | 2024-02-07 | |
| 2023-09-30 | $205,999,435 | 592,395 | Shares | Sole | 2023-11-09 | |
| 2023-06-30 | $214,911,082 | 610,699 | Shares | Sole | 2023-08-09 | |
| 2023-03-31 | $195,600,178 | 620,815 | Shares | Sole | 2023-05-12 | |
| 2022-12-31 | $225,393,364 | 780,502 | Shares | Sole | 2023-02-09 | |
| 2022-09-30 | $250,251,447 | 864,307 | Shares | Sole | 2022-11-10 | |
| 2022-06-30 | $248,438,742 | 881,645 | Shares | Sole | 2022-08-12 | |
| 2022-03-31 | $248,749,818 | 953,174 | Shares | Defined | 2022-05-13 | |
| 2021-12-31 | $205,113,646 | 934,033 | Shares | Defined | 2022-02-09 | |
| 2021-09-30 | $127,797,598 | 704,546 | Shares | Defined | 2021-11-12 | |
| 2021-06-30 | $104,650,607 | 519,023 | Shares | Defined | 2021-08-12 | |
| 2021-03-31 | $100,914,707 | 469,611 | Shares | Defined | 2021-05-14 | |
| 2020-12-31 | $107,428,110 | 454,549 | Shares | Defined | 2021-03-08 | |
| 2020-09-30 | $118,528,669 | 435,575 | Shares | Defined | 2020-11-12 | |
| 2020-06-30 | $125,399,404 | 431,950 | Shares | Defined | 2020-08-13 | |
| 2020-03-31 | $94,430,457 | 396,850 | Shares | Defined | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||